基于AI的语音生物标志物工具检测中重度抑郁信号评估
本研究为横断面研究,纳入美国与加拿大14898名英语成人,采集至少25秒自由语音,评估机器学习工具(Kintsugi Voice)检测与PHQ-9≥10(中重度抑郁)一致的语音生物标志物的效能。结果显示灵敏度71.3(95%CI 69.0-73.5)、特异度73.5(95%CI 71.5-75.5),提示该技术可能辅助基层抑郁筛查,但临床部署效果仍需进一步研究。
要点
- 机器学习语音分析可从25秒自由语音中检测与PHQ-9≥10一致的声学特征
- 灵敏度71.3%、特异度73.5%,参照PHQ-9≥10自报结果
- 仅约4%基层患者接受抑郁筛查,该工具或有助于提高筛查依从性
核心结论
- 机器学习语音检测技术对中重度抑郁信号具有潜在筛查价值,但需进一步研究临床部署效果。
研究设计与样本
- 横断面研究,2021年2月1日至2022年7月31日,纳入美国与加拿大14898名英语成人,采集至少25秒自由语音,以自报PHQ-9≥10为参照。
主要发现
- 机器学习技术从25秒自由语音中检测与PHQ-9≥10一致的声学特征,灵敏度71.3(95%CI 69.0-73.5),特异度73.5(95%CI 71.5-75.5)。
关键数值与推荐
- 以PHQ-9 cut-off评分10(中重度抑郁)为参照标准。
临床怎么用
- 该工具可能辅助全科医生对中重度抑郁进行筛查,但临床部署效果尚待验证。
局限性
- 研究为横断面设计,参与者通过社交媒体招募,结论基于自报PHQ-9而非临床诊断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Mental health screening is recommended by the US Preventive Services Task Force for all patients in areas where treatment options are available. Still, it is estimated that only 4% of primary care patients are screened for depression. The goal of this study was to evaluate the efficacy of machine learning technology (Kintsugi Voice, v1, Kintsugi Mindful Wellness, Inc) to detect and analyze voice biomarkers consistent with moderate to severe depression, potentially allowing for greater compliance with this critical primary care public health need. METHODS: We performed a cross-sectional study from February 1, 2021 to July 31, 2022 to examine ≥25 seconds of free-form speech content from English-speaking samples captured from 14,898 unique adults in the United States and Canada. Participants were recruited via social media, provided informed consent, and their voice biomarker results were compared with a self-reported Patient Health Questionnaire-9 (PHQ-9) at a cut-off score of 10 (moderate to severe depression). RESULTS: From as few as 25 seconds of free-form speech, machine learning technology was able to detect vocal characteristics consistent with an increased PHQ-9 ≥10, with a sensitivity of 71.3 (95% CI, 69.0-73.5) and a specificity of 73.5 (95% CI, 71.5-75.5). CONCLUSIONS: Machine learning has potential utility in helping clinicians screen patients for moderate to severe depression. Further research is needed to measure the effectiveness of machine learning vocal detection and analysis technology in clinical deployment.
引用
- Mazur A, Costantino H, Tom P, et al. Evaluation of an AI-Based Voice Biomarker Tool to Detect Signals Consistent With Moderate to Severe Depression. Ann Fam Med. 2025. PMID: 39805690. doi:10.1370/afm.240091
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。